Fundraising FoxIndustrifonden — 2025 Investments
6 investments dated 2025 · listed companies and verified rows first · show all
Cellevate develops Cellevat3d nanofiber-based microcarriers and cell culture systems for upstream bioprocessing, used in viral vector, viral vaccine, and stem cell production by gene therapy and biopharmaceutical organizations.
Advanced ManufacturingBiotechDeep TechMedical DevicesNew MaterialsLong Beach, US
Maximilian Ottosson(Founder)inClint Monfort(Executive Officer, Director, Promoter)
Co-investorsOnsight VenturesEuropean Investment BankEICEuropean Innovation Council Fund
Open Payments is an API aggregator that connects financial institutions and businesses to multiple banks through a single unified API, supporting account information retrieval and payment initiation under the PSD2 directive.
Data & InfrastructureEnterprise SoftwareFintechStockholm, SE
Co-investorsGlobal BrainGoose Valley VenturesLuminar VenturesAlfvén & Didrikson
Tribune Therapeutics is a preclinical biopharmaceutical company developing medicines that target CCN protein family signaling (such as CCN2/CTGF) to block fibrotic pathways.
BiotechHealthtech
Ole Kaasbøll(Co-founder)
Co-investorsHealthCapInnovestor VenturesLifeArc VenturesInvestinorNovo Holdings
Zymego provides appointment management software for healthcare clinics that enables patients to self-book, reschedule, and cancel appointments autonomously, reducing no-shows and wait times.
Digital HealthHealthtechSaaS
Ingmar Veinberg(Doctor, Founder)in
Co-investorsIcebreakerSpintop Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.